beryllium sulfate has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, AR; Gary, RK; Gorjala, P; Mudireddy, SR | 1 |
| Cairncross, JG; Gary, RK; Gorjala, P | 1 |
| Gary, RK; Gorjala, P | 1 |
3 other study(ies) available for beryllium sulfate and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium.
Topics: Beryllium; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Fibroblasts; Fluorescence Resonance Energy Transfer; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Chloride; Phosphorylation; Phosphoserine; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |
p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.
Topics: Antineoplastic Agents; Beryllium; Brain; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytostatic Agents; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; RNA Interference; RNA, Messenger; RNA, Small Interfering; Tumor Suppressor Protein p53; Up-Regulation | 2016 |
Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.
Topics: Beryllium; beta-Galactosidase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Genes, p53; Glioblastoma; Humans; Tumor Suppressor Protein p53 | 2010 |